ESSA Pharma Inc. (EPIX) Financials
EPIX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 144.5 million | 3.8 million |
2023-09-30 | 149.1 million | 3.5 million |
2023-06-30 | 153.7 million | 3.4 million |
2023-03-31 | 158.5 million | 2.2 million |
EPIX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -6.8 million | 803418 |
2023-09-30 | -4.5 million | 845697 |
2023-06-30 | -3.3 million | 1.2 million |
2023-03-31 | -7.0 million | 1.4 million |
EPIX Net Income
No data available :(
EPIX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 142.1 million | - | 374835 |
2023-09-30 | 148.1 million | - | 80328 |
2023-06-30 | 152.5 million | - | 111273 |
2023-03-31 | 44.3 million | - | 145268 |
EPIX Shares Outstanding
EPIX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 5.4 million | 2.4 million | - |
2023-09-30 | - | 5.2 million | 2.1 million | - |
2023-06-30 | - | 6.3 million | 2.8 million | - |
2023-03-31 | - | 4.5 million | 3.7 million | - |
EPIX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 29708 |
2023-09-30 | - | 27149 |
2023-06-30 | - | 30447 |
2023-03-31 | - | 30447 |
EPIX
Price: $6.88
52 week price:
Earnings Per Share: -0.59 USD
P/E Ratio: -16.33
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 44601
Ebitda: -1.8 millionMarket Capitalization: 319.8 million